Berlin-Brandenburg Center for Regenerative Therapies, CellNet Group, Berlin, Germany.
In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):242-6. doi: 10.1007/s11626-010-9295-1. Epub 2010 Feb 23.
Rapid advances in stem cell research have led to the derivation of hundreds of human embryonic stem (hES) cell lines in centers throughout the world, as well as the development of new technologies for producing pluripotent stem cells. These cell lines have unique characteristics and were derived using a variety of ethical guidelines. Stem cell registries have been developed in order to collect, organize, and disseminate cell line-specific information. In this review, we describe the current state of the field by providing an overview of the unique qualities and mandates of the three major stem cell registries: the European hES Cell Registry, the Registry of hES Cell Line Provenance developed by the International Society for Stem Cell Research, and the International Stem Cell Registry of hES and induced pluripotent stem cell lines established at the University of Massachusetts Medical School. While each registry has its own unique mandate and features, there is some overlap in the goals and information provided. This review discusses the challenges and prospects for an integrated approach in which all three registries effectively collaborate to minimize duplication and facilitate information exchange within the stem cell community.
干细胞研究的快速进展导致了数百个人类胚胎干细胞(hES)细胞系在世界各地的中心得以衍生,同时也开发了生产多能干细胞的新技术。这些细胞系具有独特的特征,并且是使用各种伦理准则衍生的。已经开发了干细胞登记处,以便收集、组织和传播与细胞系特异性相关的信息。在这篇综述中,我们通过概述三个主要的干细胞登记处的独特性质和任务来描述该领域的现状:欧洲 hES 细胞登记处、国际干细胞研究学会开发的 hES 细胞系来源登记处,以及马萨诸塞大学医学院建立的 hES 和诱导多能干细胞系国际干细胞登记处。虽然每个登记处都有其独特的任务和特点,但在目标和提供的信息方面存在一些重叠。本文讨论了一种集成方法的挑战和前景,其中三个登记处能够有效地合作,以最小化重复并促进干细胞社区内的信息交流。